Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 007370254 approvals29 trials

JIN YANG PHARMACEUTICAL. CO., LTD

Official website

Founded in 1978 and listed on the KOSDAQ in 2000, Jin Yang Pharmaceutical is a generic-drug-focused pharmaceutical company producing Sobunal and Octiran.

As of 2026-10-10, JIN YANG PHARMACEUTICAL. CO., LTD has 1 Korean MFDS device approval, 253 Korean MFDS drug approvals on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Products & technology

  • Sobunal
  • Octiran

Regulatory approvals

data.go.kr

253 Korean MFDS drug approvals · 1987–2026 / 1 Korean MFDS device approvals · 2006

  • MFDS drugPregaba Cap. 25mg2026-09-29
    Drug · Prescription · Approval202602919
  • MFDS drugPregaba Cap. 50mg2026-09-29
    Drug · Prescription · Approval202602920
  • MFDS drugSSenBQ ActB Tab.2026-07-14
    Drug · OTC · Notification202602029
  • MFDS drugRosuvzet ODT. 10/5mg2026-06-30
    Drug · Prescription · Approval202601870
  • MFDS drugRosuvzet ODT. 10/20mg2026-06-30
    Drug · Prescription · Approval202601871
  • MFDS drugRosuvzet ODT. 10/10mg2026-06-30
    Drug · Prescription · Approval202601872
  • MFDS drugEbicept Tab. 10/20mg2026-05-26
    Drug · Prescription · Approval202601506
  • MFDS drugK-PRA Tab. 25mg2026-04-14
    Drug · Prescription · Approval202601067
  • MFDS drugK-PRA Tab. 50mg2026-04-14
    Drug · Prescription · Approval202601068
  • MFDS drugPitacholin SR Tab.2026-02-26
    Drug · Prescription · Approval202600584
  • MFDS drugDentax Cap.2025-09-19
    Drug · OTC · Notification202502478
  • MFDS drugJ-Proxen Tab.2025-05-27
    Drug · OTC · Notification202501303
Show 68 more
  • MFDS drugGynocalcium Tab2025-03-13
    Drug · OTC · Notification202500556
  • MFDS drugRaivin Cap. 100mg2025-02-26
    Drug · Prescription · Approval202500420
  • MFDS drugRivin Cap. 200mg2025-02-26
    Drug · Prescription · Approval202500421
  • MFDS drugRaivin Cap. 400mg2025-02-26
    Drug · Prescription · Approval202500422
  • MFDS drugK smin Cap.2024-09-12
    Drug · OTC · Notification202402221
  • MFDS drugAllegien Tab. 60mg2024-09-03
    Drug · OTC · Notification202402141
  • MFDS drugAllegien Tab. 120mg2024-09-03
    Drug · OTC · Notification202402142
  • MFDS drugJinkgo High Tab. 240mg2024-07-30
    Drug · OTC · Notification202401838
  • MFDS drugSSenBQChondro Tab.2024-06-07
    Drug · OTC · Notification202401412
  • MFDS drugChlo High Tab.2024-04-15
    Drug · OTC · Notification202400843
  • MFDS drugNicergol Tab. 30mg(Nicergoline)2024-02-29
    Drug · Prescription · Approval202400444
  • MFDS drugWonpyo Woohwangchungsimwon Suspension2023-10-31
    Drug · OTC · Notification202303038
  • MFDS drugWonpyo Woohwangchungsimwon Liquid2023-10-31
    Drug · OTC · Notification202303039
  • MFDS drugHemoheal2023-09-22
    Drug · OTC · Notification202302807
  • MFDS drugEmpaglin Duo Tab. 12.5/850mg2023-09-14
    Drug · Prescription · Approval202302756
  • MFDS drugEmpagreen Duo Tab. 12.5/500mg2023-09-14
    Drug · Prescription · Approval202302757
  • MFDS drugEmpagreen Duo Tab. 12.5/1000mg2023-09-14
    Drug · Prescription · Approval202302758
  • MFDS drugSSenBQ Tab.2023-09-11
    Drug · OTC · Notification202302710
  • MFDS drugPROSEA Prefilled Inj.2023-08-16
    Drug · Prescription · Approval202302442
  • MFDS drugARIA DS Tab.2023-08-10
    Drug · Prescription · Approval202302398
  • MFDS drugBBN Tab.2023-05-25
    Drug · OTC · Notification202301678
  • MFDS drugUrincool Cap.2023-04-18
    Drug · OTC · Notification202301269
  • MFDS drugMecoMagBig Tab.2023-04-18
    Drug · OTC · Notification202301270
  • MFDS drugBenfo B Power Tablet2023-04-05
    Drug · OTC · Notification202301146
  • MFDS drugPiroxhigh gel2023-03-22
    Drug · OTC · Notification202300999
  • MFDS drugDAPAGREEN-G TAB. 10/4mg2023-02-22
    Drug · Prescription · Approval202300664
  • MFDS drugDAPAGREEN TAB. 10mg2023-01-31
    Drug · Prescription · Approval202300420
  • MFDS drugDAPAGREEN TAB. 5mg2023-01-31
    Drug · Prescription · Approval202300421
  • MFDS drugE Q Pen Kids A Syrup2023-01-30
    Drug · OTC · Notification202300373
  • MFDS drugE Q Pen Kids I2023-01-11
    Drug · OTC · Notification202300213
  • MFDS drugSSenBQM Tab.2022-07-04
    Drug · OTC · Notification202202769
  • MFDS drugEmpagreenDuo Tab. 5/1000mg2022-04-04
    Drug · Prescription · Approval202201342
  • MFDS drugEmpagreenDuo Tab. 5/850mg2022-04-04
    Drug · Prescription · Approval202201343
  • MFDS drugEmpagreenDuo Tab. 5/500mg2022-04-04
    Drug · Prescription · Approval202201344
  • MFDS drugTENEGREEN DUO SR TAB. 20/1000mg2022-04-04
    Drug · Prescription · Approval202201438
  • MFDS drugTENEGREEN DUO SR TAB. 10/750mg2022-04-04
    Drug · Prescription · Approval202201439
  • MFDS drugTENEGREEN DUO SR TAB. 10/500mg2022-04-04
    Drug · Prescription · Approval202201440
  • MFDS drugJANUGREEN DUO TAB. 50/850mg2022-03-02
    Drug · Prescription · Approval202200910
  • MFDS drugJANUGREEN DUO TAB. 50/500mg2022-03-02
    Drug · Prescription · Approval202200911
  • MFDS drugJANUGREEN DUO TAB. 50/1000mg2022-03-02
    Drug · Prescription · Approval202200912
  • MFDS drugDAPAGREEN-S TAB. 10/100mg2022-01-04
    Drug · Prescription · Approval202200065
  • MFDS drugTENEGREEN TAB.2021-10-20
    Drug · Prescription · Approval202107033
  • MFDS drugESZOL DUO TAB. 20/800mg2021-06-24
    Drug · Prescription · Approval202104835
  • MFDS drugRecuvi Nuro Tab.Revoked2021-05-17
    Drug · OTC · Notification202103897
  • MFDS drugEmpagreen Tab. 25mgRevoked2021-03-12
    Drug · Prescription · Approval202102263
  • MFDS drugEmpagreen Tab. 10mgRevoked2021-03-12
    Drug · Prescription · Approval202102264
  • MFDS drugJINTOZET TAB. 10/40mg2021-02-18
    Drug · Prescription · Approval202101407
  • MFDS drugJINTOZET TAB. 10/20mg2021-02-18
    Drug · Prescription · Approval202101408
  • MFDS drugJINTOZET TAB. 10/10mg2021-02-18
    Drug · Prescription · Approval202101409
  • MFDS drugJinyang Naproxen Soft Cap.Revoked2020-11-24
    Drug · OTC · Notification202008137
  • MFDS drugJinyang Nafamostat Mesilate Inj. 50mgRevoked2020-11-20
    Drug · Prescription · Approval202008085
  • MFDS drugJinyang Nafamostat Mesilate Inj. 10mgRevoked2020-11-20
    Drug · Prescription · Approval202008086
  • MFDS drugRecuvi EX Tab.Revoked2020-09-18
    Drug · OTC · Notification202006434
  • MFDS drugJanugreen Tab. 25mg2020-08-20
    Drug · Prescription · Approval202005910
  • MFDS drugJanugreen Tab. 50mg2020-08-20
    Drug · Prescription · Approval202005911
  • MFDS drugJanugreen Tab. 100mg2020-08-20
    Drug · Prescription · Approval202005912
  • MFDS drugRosuvzet Tab. 10/5mg2020-06-23
    Drug · Prescription · Approval202004602
  • MFDS drugRosuvzet Tab. 10/10mg2020-06-23
    Drug · Prescription · Approval202004603
  • MFDS drugRosuvzet Tab. 10/20mg2020-06-23
    Drug · Prescription · Approval202004604
  • MFDS drugLaszol Cap. 15mgRevoked2020-05-26
    Drug · Prescription · Approval202003884
  • MFDS drugLaszol Cap. 30mgRevoked2020-05-26
    Drug · Prescription · Approval202003885
  • MFDS drugLinagreen Duo Tab. 2.5/1000mgRevoked2020-05-19
    Drug · Prescription · Approval202003651
  • MFDS drugLinagreen Duo Tab. 2.5/850mgRevoked2020-05-19
    Drug · Prescription · Approval202003652
  • MFDS drugLinagreen Duo Tab. 2.5/500mgRevoked2020-05-19
    Drug · Prescription · Approval202003653
  • MFDS drugPrejin SR Cap. 100mgRevoked2020-05-08
    Drug · Prescription · Approval202003333
  • MFDS drugPrejin SR Cap. 200mgRevoked2020-05-08
    Drug · Prescription · Approval202003334
  • MFDS drugOlobica HCT Tab. 10/40/12.5mgRevoked2020-05-06
    Drug · Prescription · Approval202003283
  • MFDS drugOlobica HCT Tab. 5/20/12.5mgRevoked2020-05-06
    Drug · Prescription · Approval202003284

Showing the 80 most recent of 254 records.

Clinical trials

data.go.kr

29 MFDS clinical trial authorisations · 2014–2026 (Bioequivalence 20 · Phase 1 8 · Phase 3 1)

  • BioequivalenceJY6012026-08-04

    1 trial site

  • Phase 1JY5012026-05-29

    1 trial site

  • BioequivalenceJY4112026-01-02

    1 trial site

  • Phase 1JY4092025-11-17

    2 trial sites

  • Bioequivalence쎄클래신건조시럽125mg/5mL(클래리트로마이신)2025-07-16

    2 trial sites

  • Phase 1JY4092025-06-25

    2 trial sites

  • BioequivalenceJY4102025-06-12

    2 trial sites

  • Phase 1JY4082025-04-24

    2 trial sites

  • Bioequivalence쎄클래신건조시럽250mg/5mL(클래리트로마이신)2025-03-31

    2 trial sites

  • Phase 1JY4092025-03-20

    2 trial sites

  • Phase 1JY4082025-01-24

    2 trial sites

  • BioequivalenceJY4012024-03-11

    2 trial sites

Show 17 more
  • Phase 1JY3032024-02-06

    1 trial site

  • Phase 3JY3032023-11-20

    6 trial sites

  • Bioequivalence테라캡정50밀리그램2023-09-05

    2 trial sites

  • Bioequivalence암발탄정10/160밀리그램2022-02-22

    2 trial sites

  • Phase 1JY3022022-01-28

    2 trial sites

  • Bioequivalence테미스타정80/5밀리그램2021-12-28

    2 trial sites

  • Bioequivalence다파그린정10밀리그램2021-12-13

    2 trial sites

  • Bioequivalence암발탄정10/160밀리그램2021-04-29

    2 trial sites

  • Bioequivalence암발탄정10/160밀리그램2020-02-06

    2 trial sites

  • Bioequivalence아토브젯정10/40밀리그램2019-11-18

    2 trial sites

  • Bioequivalence진양 텔미사르탄/암로디핀베실산염정 80/5밀리그램2015-12-03
  • Bioequivalence에스졸정40밀리그램(에스오메프라졸마그네슘삼수화물)2015-11-26

    3 trial sites

  • Bioequivalence베스디핀정(암로디핀베실산염)2015-07-10

    2 trial sites

  • Bioequivalence모가톤정(이토프리드염산염)2015-07-08

    2 trial sites

  • Bioequivalence로수바틴정20밀리그램(로수바스타틴칼슘)2014-10-30

    2 trial sites

  • Bioequivalence아토란정20밀리그램2014-10-01

    2 trial sites

  • Bioequivalence쎄브렉스캡슐 200 밀리그램(세레콕시브)2014-07-07

    2 trial sites

R&D and key agreements

Source: DART corporate disclosure

제네릭 의약품 개발 및 제형 연구 · The Life Science Research Institute, located at the Seoul National University College of Pharmacy New Drug Development Center, develops generic drug products and conducts formulation stability research, staffed by 8 people including the director.

Key disclosures

KRX KIND via OpenDART

Patents

KIPRIS · applicant-matched
Show 14 more patents

AI reads

MAA server logs · IP-verified
77
Times AI engines pulled JIN YANG PHARMACEUTICAL. CO., LTD's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

3
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

74
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

14
live 1
Last 7 days
59
live 2
Last 30 days
77
live 3
All time
  • OpenAIChatGPT-Userlive3
  • OpenAIOAI-SearchBot66
  • GoogleGoogleOther2
  • MicrosoftBingbot2
  • PerplexityPerplexityBot2
  • AnthropicClaudeBot2

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for JIN YANG PHARMACEUTICAL. CO., LTD and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

DAE HWA PHARM CO., LTD1 shared

KOSDAQ-listed pharmaceutical company behind the world's first oral paclitaxel Liporaxel (DHP107) and the Amalian dermal filler.

DONG-A ST CO.,LTD1 shared

Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.

JEIL PHARMA HOLDINGS INC.1 shared

Founded in 1959 and listed on KOSPI in 1988, Jeil Pharma Holdings is a pharmaceutical holding company whose subsidiaries include Jeil Pharm.

KyungdongPharm1 shared

Founded in 1976, Kyungdong Pharm produces prescription drugs including Duorovan and Baldipine, and launched the health-food brand WIAVIM.

SINSIN PHARMACEUTICAL Co., LTD.1 shared

Sinsin Pharmaceutical sells medicated patches and OTC medicines through direct deals with over 13,000 pharmacies nationwide.

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition